IMG-004

N/A

Report date: 2024/05/20 16:19:28
NME

Base Information

Drug NameIMG-004
Drug Alias NameIMG-004
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionTyrosine-protein kinase BTK inhibitors
TargetsTyrosine-protein kinase BTK
Therapy Area/IndicationsChronic Urticaria
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesMainland China
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaPhase 1 Clinical
Originator CompaniesHutchmed (China) Ltd
China Registration ClassClass 1 Chemical Drug in China

Develop Information

Active CompaniesInmagene LLCInmagene Biopharmaceuticals (Hangzhou) Co Ltd
Inactive CompaniesN/A
Active IndicationsChronic Urticaria
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A